Patent | Date |
---|
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use Grant 10,556,914 - Dinges , et al. Feb | 2020-02-11 |
Substituted Isoxazolopyridazinones And Isothiazolopyridazinones And Methods Of Use App 20190367531 - DINGES; Jurgen ;   et al. | 2019-12-05 |
Inhibitor compounds of phosphodiesterase type 10A Grant 10,308,610 - Geneste , et al. | 2019-06-04 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20180222905 - Geneste; Herve ;   et al. | 2018-08-09 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20180099936 - Geneste; Herve ;   et al. | 2018-04-12 |
Inhibitor compounds of phosphodiesterase type 10A Grant 9,938,269 - Geneste , et al. April 10, 2 | 2018-04-10 |
Inhibitor compounds of phosphodiesterase type 10A Grant 9,856,220 - Geneste , et al. January 2, 2 | 2018-01-02 |
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors Grant 9,657,034 - Geneste , et al. May 23, 2 | 2017-05-23 |
Substituted Isoxazolopyridazinones And Isothiazolopyridazinones And Methods Of Use App 20170073353 - DINGES; Jurgen ;   et al. | 2017-03-16 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160318871 - Geneste; Herve ;   et al. | 2016-11-03 |
Inhibitor compounds of phosphodiesterase type 10A Grant 9,475,808 - Geneste , et al. October 25, 2 | 2016-10-25 |
Treatment of central nervous system disorders Grant 9,464,072 - Bitner , et al. October 11, 2 | 2016-10-11 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Grant 9,388,148 - Haupt , et al. July 12, 2 | 2016-07-12 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Grant 9,388,141 - Haupt , et al. July 12, 2 | 2016-07-12 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Grant 9,376,396 - Haupt , et al. June 28, 2 | 2016-06-28 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160137668 - GENESTE; Herve ;   et al. | 2016-05-19 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,290,444 - Bitner , et al. March 22, 2 | 2016-03-22 |
Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A Grant 9,273,068 - Geneste , et al. March 1, 2 | 2016-03-01 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20160002231 - GENESTE; Herve ;   et al. | 2016-01-07 |
Inhibitor compounds of phosphodiesterase type 10A Grant 9,200,005 - Jantos , et al. December 1, 2 | 2015-12-01 |
Inhibitor compounds of phosphodiesterase type 10A Grant 9,163,019 - Geneste , et al. October 20, 2 | 2015-10-20 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150265613 - Bitner; R. Scott ;   et al. | 2015-09-24 |
Treatment Of Central Nervous System Disorders App 20150099740 - Bitner; R. Scott ;   et al. | 2015-04-09 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,993,632 - Bitner , et al. March 31, 2 | 2015-03-31 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150065508 - Bitner; R. Scott ;   et al. | 2015-03-05 |
Treatment of central nervous system disorders Grant 8,940,902 - Bitner , et al. January 27, 2 | 2015-01-27 |
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor App 20140303176 - HAUPT; Andreas ;   et al. | 2014-10-09 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20140303153 - GENESTE; Herve ;   et al. | 2014-10-09 |
Novel inhibitor compounds of phosphodiesterase type 10A App 20140275069 - JANTOS; Katja ;   et al. | 2014-09-18 |
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor App 20140275104 - HAUPT; Andreas ;   et al. | 2014-09-18 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,716,345 - Bitner , et al. May 6, 2 | 2014-05-06 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116229 - Geneste; Herve ;   et al. | 2013-05-09 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116241 - Geneste; Herve ;   et al. | 2013-05-09 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130116233 - Geneste; Herve ;   et al. | 2013-05-09 |
Treatment Of Central Nervous System Disorders App 20130059829 - Bitner; R. Scott ;   et al. | 2013-03-07 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130045978 - Bitner; R. Scott ;   et al. | 2013-02-21 |
Novel Inhibitor Compounds Of Phosphodiesterase Type 10a App 20130005705 - Geneste; Herve ;   et al. | 2013-01-03 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20120289512 - Bitner; R. Scott ;   et al. | 2012-11-15 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,198,331 - Bitner , et al. June 12, 2 | 2012-06-12 |
N-acylsulfonamide apoptosis promoters Grant 7,754,886 - Augeri , et al. July 13, 2 | 2010-07-13 |
Treatment Of Central Nervous System Disorders App 20100152179 - Bitner; R. Scott ;   et al. | 2010-06-17 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) Grant 7,671,076 - Akritopoulou-Zanze , et al. March 2, 2 | 2010-03-02 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192198 - Bitner; R. Scott ;   et al. | 2009-07-30 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090176783 - Bitner; R. Scott ;   et al. | 2009-07-09 |
N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ;   et al. | 2009-05-28 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,528,282 - Rohde , et al. May 5, 2 | 2009-05-05 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,511,175 - Patel , et al. March 31, 2 | 2009-03-31 |
N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2 | 2009-03-17 |
Treatment Of Central Nervous System Disorders App 20090054426 - Bitner; R. Scott ;   et al. | 2009-02-26 |
Tricyclic pyrazole kinase inhibitors Grant 7,468,371 - Arnold , et al. December 23, 2 | 2008-12-23 |
Pharmaceutical Compositions As Inhibitors Of Dipeptidyl Peptidase-iv (dpp-iv) App 20080119464 - Akritopoulou-Zanze; Irini ;   et al. | 2008-05-22 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) Grant 7,348,346 - Akritopoulou-Zanze , et al. March 25, 2 | 2008-03-25 |
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20070179186 - Rohde; Jeffrey J. ;   et al. | 2007-08-02 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,217,838 - Rohde , et al. May 15, 2 | 2007-05-15 |
Method Of Inhibiting Angiogenesis App 20070043089 - HAVIV; FORTUNA ;   et al. | 2007-02-22 |
Method Of Inhibiting Angiogenesis App 20070032527 - Haviv; Fortuna ;   et al. | 2007-02-08 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme App 20060281773 - Patel; Jyoti R. ;   et al. | 2006-12-14 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme App 20060149070 - Rohde; Jeffrey J. ;   et al. | 2006-07-06 |
Substituted pyridines having antiangiogenic activity App 20060030557 - Haviv; Fortuna ;   et al. | 2006-02-09 |
Tricyclic pyrazole kinase inhibitors App 20060014816 - Arnold; Lee D. ;   et al. | 2006-01-19 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) App 20050215603 - Akritopoulou-Zanze, Irini ;   et al. | 2005-09-29 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) App 20050209249 - Akritopoulou-Zanze, Irini ;   et al. | 2005-09-22 |
Kinase inhibitors Grant 6,831,175 - Li , et al. December 14, 2 | 2004-12-14 |
N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ;   et al. | 2004-09-30 |
Method of inhibiting angiogenesis App 20040116479 - Haviv, Fortuna ;   et al. | 2004-06-17 |
N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2 | 2004-04-13 |
Method of inhibiting angiogenesis App 20040067985 - Haviv, Fortuna ;   et al. | 2004-04-08 |
Substituted pyridines having antiangiogenic activity App 20040014744 - Haviv, Fortuna ;   et al. | 2004-01-22 |
Kinase inhibitors App 20030199511 - Li, Qun ;   et al. | 2003-10-23 |
Substituted pyridines having antiangiogenic activity App 20030195195 - Haviv, Fortuna ;   et al. | 2003-10-16 |
Kinase inhibitors App 20030187026 - Li, Qun ;   et al. | 2003-10-02 |
Aminal diones as potassium channel openers App 20020165264 - Kort, Michael E. ;   et al. | 2002-11-07 |
Aminal Diones as potassium channel openers App 20020147230 - Kort, Michael E. ;   et al. | 2002-10-10 |
N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ;   et al. | 2002-07-04 |
N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ;   et al. | 2002-05-09 |
Quinoline and naphthyridine carboxylic acid antibacterials App 20020049223 - Elmore, Steven W. ;   et al. | 2002-04-25 |